key: cord-261113-v84rzhin
authors: Ferdinand, Keith C.
title: Understanding African American COVID‐19 Severity and Mortality: Is Obesity the Key?
date: 2020-08-04
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.22938
sha: 
doc_id: 261113
cord_uid: v84rzhin

nan

Recently, two Obesity journal reports were published indicating the role of obesity, especially in AA (3, 4) . However, the disproportionate COVID-19 mortality in AA and other disadvantaged groups reflects long-standing systemic health inequalities and diminished life expectancy. Well before the existence of COVID-19, adverse factors, including poorer underlying health, barriers to preventive health care, absent or substandard health insurance, and at-risk occupational exposures, disproportionately affected racial/ethnic minorities (5,6). Pulmonary complications do not fully capture the breadth of COVID-19 morbidity and mortality. Severe acute respiratory syndrome coronavirus 2 infection is also associated with cardiovascular disease complications and associated risk factors.

In recognition of the distressingly high COVID-19 outcomes in AA, two important single-site studies have been published from New Orleans, Louisiana, and Chicago, Illinois, both early US COVID-19 pandemic hot spots. Adiposity is clearly associated with multiple conditions and variables and is not definitively an independent COVID-19 severity risk factor. However, the increased obesity-COVID-19 association was recognized previously in Seattle, Washington, including severity and specific critical findings (7).

One present study by Alkhatib and colleagues (3), a retrospective sample of 158 consecutive patients from a tertiary center in New Orleans, measured BMI as a continuous variable and intensive care unit admissions as an end point. Although, overall, patients with severe disease were older (62 vs. 55 years, P = 0.003), the mean age was relatively young at 57 years, with 61% women. These findings are somewhat at odds with the concept that COVID-19 severity is predominantly seen in persons over 65 and closely linked to male sex. Adjusting for other comorbidities and stratifying, BMI greater than 40 kg/m 2 was associated with severe disease with an odds ratio of 20.83. In this entirely AA sample, diabetes mellitus and chronic kidney disease were also significantly higher in patients with severe disease (P = 0.022 and 0.019, respectively). It is heartening that the authors call for more inclusive research aimed at optimizing clinical care relevant to the AA population and a more equitable response to COVID-19 (3).

Although exact mechanisms for death in this sample are largely unknown, clinicians can add obesity as a potential signal for increased respiratory distress and mortality (4) . In patients with obesity and severe obesity, associated factors of decreased expiratory reserve volume, functional capacity, respiratory system compliance, compromised function in supine patients by decreased diaphragmatic excursion, and increased inflammatory cytokines may contribute to the increased morbidity associated with obesity in COVID-19 infections (4).

Accordingly, in a recent large case series of 5,700 patients hospitalized with COVID-19 in the New York City area, including 1,230 (22.6%) AA, obesity was reported to increase the odds ratio for death by 3.05 (95% CI: 1.57-5.92) (8) . Moreover, among 3,615 individuals in a large New York City academic hospital, without defined percentages based on race/ethnicity, obesity and COVID-19 appeared to affect severity at younger ages. For those aged less than 60 years, those with BMI between 30 and 34 kg/m 2 and those with BMI > 35 kg/m 2 , compared with those of normal weight, were 1.8 times and 3.6 times more likely, respectively, to be admitted to critical care (9) . Similarly, in 265 patients (58% male) from several US university hospitals, obesity was a salient risk factor for severe COVID-19 disease. The authors proposed increased public messaging to younger adults, proactive virus testing in individuals with obesity, and maintaining greater vigilance for this at-risk population to help ameliorate widespread, severe COVID-19 disease (10) .

It is difficult to disaggregate obesity-associated COVID-19 mortality from hypertension and diabetes to prove a cause-effect relationship. However, heightened obesity-related metabolic and inflammatory pathways may adversely alter the course of COVID-19 and individuals with obesity. This may amplify or dysregulate immune responses, with excess adipose tissue leading to virus-activated cytokine storm syndrome (11) . Patients with COVID-19 and diabetes appear significantly more likely to die compared with those without diabetes (7.8% vs. 2.7%; P < 0.001), with a crude hazard ratio of 2.90 (P < 0.001). Hence, obesity and associated uncontrolled diabetes may be a risk factor for rapid progression and poorer prognosis of COVID-19 (12) . Obesity | VOLUME 00 | NUMBER 00 | MONTH 2020 www.obesityjournal.org

Moreover, hypertension may additionally lead to increased severity. (14, 15) . Therefore, the COVID-19 pandemic offers an opportunity to more effectively address the obesity "epidemic," including youth primordial prevention, especially in US minorities, before obesity becomes evident. Instead of stigmatization of black adults with obesity, this pandemic, a hopefully once-in-a-century health crisis, is a clarion call to decrease and eventually eliminate long-standing health disparities and underlying adverse societal structural factors (16, 17) .O

World Health Organization. Global Health Observatory (GHO) data: overweight and obesity

Prevalence of obesity and severe obesity among adults: United States

Body mass index is associated with COVID-19 intensive care unit admission in African Americans

Obesity and its implications for COVID-19 mortality

Health equity considerations and racial and ethnic minority groups

COVIDVIEW, a weekly surveillance summary of U.S. COVID-19 activity

Covid-19 in critically ill patients in the Seattle region -case series

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Obesity could shift severe COVID-19 disease to younger ages

Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms

Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes

Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression

People at increased risk and other people who need to take extra precautions

Guidance: staying alert and safe (social distancing). Gov.UK website

African-American COVID-19 mortality: a sentinel event

Primordial prevention of cardiovascular disease in childhood: the time is now